Cost-effectiveness analysis of ocriplasmin versus watchful waiting for treatment of symptomatic vitreomacular adhesion in the US.
Publication/Presentation Date
3-1-2020
Volume
9
Issue
4
First Page
287
Last Page
305
ISSN
2042-6313
Published In/Presented At
Khanani, A. M., Dugel, P. U., Haller, J. A., Wagner, A. L., Lescrauwaet, B., Schmidt, R., & Bennison, C. (2020). Cost-effectiveness analysis of ocriplasmin versus watchful waiting for treatment of symptomatic vitreomacular adhesion in the US. Journal of comparative effectiveness research, 9(4), 287–305. https://doi.org/10.2217/cer-2019-0117
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
31961196
Department(s)
Administration and Leadership
Document Type
Article
COinS